생체 흡수성 의료 재료 시장 보고서(2025년)
Bioresorbable Medical Material Global Market Report 2025
상품코드 : 1824343
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

생체 흡수성 의료 재료 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 10.0%를 나타내 25억 1,000만 달러로 성장할 것으로 예상됩니다. 예측 기간의 성장은 생체 흡수성 스캐폴드 수요 증가, 다양한 의료 용도에 생체 흡수성 재료의 채용, 심장혈관과 정형외과 수술 증가, 환자의 쾌적성과 회복에 대한 주목 증가, 조직 공학에의 응용 확대 등에 기인하고 있습니다. 예측 기간의 주요 동향으로는 특정 의료 용도를 위한 생체 흡수성 재료의 커스터마이징, 약물 전달 시스템에서의 생체 흡수성 재료의 통합, 생체 흡수성 의료기기 제조에서의 3d 프린팅의 성장, 생체 흡수성 요소를 포함한 조합 제품의 개발, 지속 가능하고 환경 친화적인 의료 재료의 중시 등이 있습니다.

향후 5년간의 성장률 10.0%라고 하는 예측은 전회 예측으로부터 0.2%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세 장벽은 핀란드와 이탈리아에서 공급되는 흡수성 스텐트와 조직 비계의 비용을 상승시키고 차세대 임플란트의 채용을 지연시키고 수술 비용을 상승시킴으로써 미국의 수술 혁신을 방해할 것으로 예측됩니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

수술 건수 증가가 향후 생체 흡수성 의료 재료 시장 성장을 이끌 것으로 예측됩니다. 수술 절차는 절개하고 도구를 사용하고 생체 내 질병을 다루거나 수리해야 하는 치료를 포함합니다. 생체 흡수성 폴리머는 특히 신경학, 정형외과 및 미용 수술 분야에서 성형 의료기기에 사용됩니다. 이 재료는 봉합사, 앵커, 나사 제조에 채택됩니다. 예를 들어 2024년 6월 미국에 본사를 둔 국제미용정형외과학회(ISAPS)는 2023년 미용 성형 수술이 3,500만 건 가까이에 이르렀으며, 수술과 비수술 수술의 총 건수가 3.4% 증가한 3,490만 건에 달했다고 보고했습니다. 그 결과, 수술 건수 증가가 생체 흡수성 의료 재료 시장 성장에 박차를 가하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

Bioresorbable medical materials are substances specifically engineered to be absorbed or broken down by the body over time. These materials find applications in various medical scenarios, including surgical implants and tissue engineering scaffolds. They offer several advantages compared to permanent implants, as they eliminate the need for surgical removal once they have fulfilled their intended function.

The primary types of bioresorbable medical materials include polylactic acid (PLA), polyglycolic acid (PGA), polysaccharides, polycaprolactone (PCL), and polylactic-co-glycolic acid (PLGA). Polylactic acid (PLA) is a biodegradable and bioresorbable polymer derived from renewable sources such as corn starch or sugarcane. PLA is commonly utilized in the production of bioresorbable medical materials, such as sutures, screws, and bone fixation devices. These materials serve diverse applications, including drug delivery and orthopedics, and are utilized by various end-users such as hospitals, clinics, ambulatory surgical centers, and research institutes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The bioresorbable medical material research report is one of a series of new reports from The Business Research Company that provides bioresorbable medical material market statistics, including the bioresorbable medical material industry's global market size, regional shares, competitors with a bioresorbable medical material market share, detailed bioresorbable medical material market segments, market trends and opportunities, and any further data you may need to thrive in the bioresorbable medical material industry. This bioresorbable medical material market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The bioresorbable medical material market size has grown strongly in recent years. It will grow from $1.56 billion in 2024 to $1.71 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to traditional non-resorbable materials limitations, advancements in polymer science, surge in cardiovascular interventions, growing aging population, expansion of minimally invasive surgeries.

The bioresorbable medical material market size is expected to see strong growth in the next few years. It will grow to $2.51 billion in 2029 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to increasing demand for bioresorbable scaffolds, adoption of bioresorbable materials in various medical applications, rise in cardiovascular and orthopedic procedures, growing focus on patient comfort and recovery, expanding applications in tissue engineering. Major trends in the forecast period include customization of bioresorbable materials for specific medical applications, integration of bioresorbable materials in drug delivery systems, growth of 3d printing in bioresorbable medical device manufacturing, development of combination products with bioresorbable elements, emphasis on sustainable and environmentally friendly medical materials,.

The forecast of 10.0% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. surgical innovation by increasing the cost of absorbable stents and tissue scaffolds sourced from Finland and Italy, thereby delaying adoption of next-generation implants and elevating surgical procedure costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising number of surgeries is expected to drive the growth of the bioresorbable medical material market in the future. Surgical procedures involve medical treatments that require making an incision and utilizing tools to address or repair diseases within a living body. Bioresorbable polymers are utilized in molded medical devices, especially in the fields of neurology, orthopedics, and cosmetic surgery. These materials can be employed to manufacture sutures, anchors, and screws. For example, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based organization, reported that aesthetic procedures approached nearly 35 million in 2023, with the total number of surgical and non-surgical procedures increasing by 3.4% to 34.9 million. Consequently, the growing number of surgeries is fueling the growth of the bioresorbable medical material market.

The burgeoning aging population is poised to drive the growth of the bioresorbable medical material market significantly. An aging population signifies a demographic shift marked by a higher percentage of individuals aged 65 and above within a society. The increased demand for medical interventions among the elderly, coupled with a preference for advanced bioresorbable solutions that alleviate the necessity for subsequent surgeries to remove implants, fuels the expansion of the bioresorbable medical materials market. For instance, in 2022, according to visual capitalist, a Canadian company specializing in visual content on contemporary trends, the global population aged 65+ years totaled 771 million, accounting for nearly 10% of the world's populace. Therefore, the growing aging demographic is a key driver behind the growth of the bioresorbable medical material market.

The emergence of innovative biomaterials is a significant trend gaining traction in the bioresorbable medical material market. Key players in this sector are concentrating on creating new biomaterials for 3D printing applications to maintain their market presence. For example, in September 2023, Zeus, a South Carolina-based company known for its advanced polymer solutions across various industries, including medical, aerospace, energy, automotive, and fiber optics, introduced next-generation tubing for bioresorbable vascular scaffolds called Absorv(TM) XSE. This product aims to enhance medical device capabilities, especially in vascular treatments. Absorv(TM) XSE represents a major advancement in bioresorbable medical devices, potentially improving patient outcomes and broadening treatment options. This innovative offering allows for extensive customization with a variety of polymer choices and expanded sizes, which facilitate tailored mechanical and absorption properties. It also ensures improved wall thickness uniformity for consistent production and provides approximately 25% more usable scaffolds post-laser cutting compared to previous models.

Leading companies in the bioresorbable medical material market are focusing on new product launches to gain a competitive advantage. For instance, in October 2023, Ashland Global, a US-based chemicals company, unveiled its bioresorbable polymers technology platform. This adaptable platform can be extended across various market segments and applications, including long-acting injectables for chronic disease management and animal health, advanced drug delivery systems to enhance mRNA delivery, as well as applications in medical devices and regenerative medicine, such as dermal fillers, sutures, screws, and other products.

In April 2024, ProMed Pharma, a US-based contract manufacturer specializing in polymer-based drug-releasing dosage forms and combination device components, acquired SpineThera for an undisclosed sum. This acquisition is strategically aimed at bolstering ProMed Pharma's market position by enhancing its manufacturing capabilities, broadening its product range, and supporting innovative drug development efforts. SpineThera is a US-based clinical-stage pharmaceutical company focused on creating innovative injectable drugs, particularly through its proprietary micro-suspension platform technology.

Major companies operating in the bioresorbable medical material market include Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Kureha Corporation, Evonik Industries AG, Stryker Corporation, Toray Industries Inc., Mitsui Chemicals Inc., Arkema S.A., Royal DSM N.V., Zimmer Biomet Holdings Inc., Ashland Global Holdings Inc., Corbion N.V., Zeus Industrial Products Inc., Unitika Ltd., Danimer Scientific, Synbra Technology, KLS Martin Group, Durect Corporation, Putnam Plastics Corporation, Zhejiang Haizheng Biomaterials Co. Ltd., NatureWorks LLC, Foster Corporation, Poly-Med Inc., Futerro S.A., TotalEnergies Corbion B.V.

North America was the largest region in the bioresorbable medical material market in 2024. Asia-Pacific is expected to be the fastest-growing region in the bioresorbable medical material market report during the forecast period. The regions covered in the bioresorbable medical material market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bioresorbable medical material market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bioresorbable medical materials market consists of sales of chitosan, collagen, and calcium phosphates. Values in this market are 'factory gat' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bioresorbable Medical Material Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bioresorbable medical material market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for bioresorbable medical material ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bioresorbable medical material market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Bioresorbable Medical Material Market Characteristics

3. Bioresorbable Medical Material Market Trends And Strategies

4. Bioresorbable Medical Material Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Bioresorbable Medical Material Growth Analysis And Strategic Analysis Framework

6. Bioresorbable Medical Material Market Segmentation

7. Bioresorbable Medical Material Market Regional And Country Analysis

8. Asia-Pacific Bioresorbable Medical Material Market

9. China Bioresorbable Medical Material Market

10. India Bioresorbable Medical Material Market

11. Japan Bioresorbable Medical Material Market

12. Australia Bioresorbable Medical Material Market

13. Indonesia Bioresorbable Medical Material Market

14. South Korea Bioresorbable Medical Material Market

15. Western Europe Bioresorbable Medical Material Market

16. UK Bioresorbable Medical Material Market

17. Germany Bioresorbable Medical Material Market

18. France Bioresorbable Medical Material Market

19. Italy Bioresorbable Medical Material Market

20. Spain Bioresorbable Medical Material Market

21. Eastern Europe Bioresorbable Medical Material Market

22. Russia Bioresorbable Medical Material Market

23. North America Bioresorbable Medical Material Market

24. USA Bioresorbable Medical Material Market

25. Canada Bioresorbable Medical Material Market

26. South America Bioresorbable Medical Material Market

27. Brazil Bioresorbable Medical Material Market

28. Middle East Bioresorbable Medical Material Market

29. Africa Bioresorbable Medical Material Market

30. Bioresorbable Medical Material Market Competitive Landscape And Company Profiles

31. Bioresorbable Medical Material Market Other Major And Innovative Companies

32. Global Bioresorbable Medical Material Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bioresorbable Medical Material Market

34. Recent Developments In The Bioresorbable Medical Material Market

35. Bioresorbable Medical Material Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기